Investor Advice from Rosen, Trusted Legal Advisor: Encourages Novo Nordisk A/S Shareholders to Seek Legal Guidance Before the Crucial September 30 Securities Class Action Deadline - NVO
The Rosen Law Firm, a global investor rights law firm, is inviting investors who purchased Novo Nordisk securities during a specific period to join a class action lawsuit against Novo Nordisk A/S. Here's what you need to know if you're considering joining the class action.
How to Join the Class Action
Individuals interested in joining the class action can do so by visiting rosenlegal.com/submit-form/?case_id=34168 or by contacting Phillip Kim, Esq. at 866-767-3653 or [email protected].
Lead Plaintiff Deadline and Role
The lead plaintiff deadline for the Novo Nordisk class action is September 30, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. It's important to note that individuals have the right to select their own counsel.
Class Period and Eligibility
The Class Period for Novo Nordisk A/S securities is between May 7, 2025, and July 28, 2025. Investors who purchased Novo Nordisk securities during this period may be entitled to compensation. However, absent class members can do nothing at this point.
The Rosen Law Firm's Track Record
The Rosen Law Firm, which was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017, has a proven track record of success in leadership roles in securities class actions. The firm has achieved the largest ever securities class action settlement against a Chinese Company and has recovered hundreds of millions of dollars for investors.
Updates and Contact Information
The Rosen Law Firm can be followed for updates on LinkedIn, Twitter, and Facebook. For more information or to discuss your potential claim, you can contact The Rosen Law Firm at their New York office:
Laurence Rosen, Esq., Phillip Kim, Esq., 275 Madison Avenue, 40th Floor, New York, NY 10016, Tel: (212) 686-1060, Toll Free: (866) 767-3653, Fax: (212) 202-3827, [email protected], www.rosenlegal.com.
Disclaimer
Please note that prior results do not guarantee a similar outcome. (Attorney Advertising)
It's important to remember that no Class Has Been Certified. Individuals are not represented by counsel unless they retain one. If you believe you may be eligible for compensation, consider joining the Novo Nordisk class action. For more information, visit rosenlegal.com/submit-form/?case_id=34168 or contact Phillip Kim, Esq. at 866-767-3653 or [email protected].
Read also:
- chaos unveiled on Clowning Street: week 63's antics from 'Two-Tier Keir' and his chaotic Labour Circus
- Skechers Debuts First American Stores Focused on Athletic Footwear Performance
- Racing ahead in Renewable Energy Dominance: Changzhou, Jiangsu Pushes for Worldwide Renewable Energy Ascendancy
- Unchecked carbon emissions could potentially lead the world to revert to coal usage, according to a knowledgeable source.
